Fjarde Ap Fonden Charles River Laboratories International, Inc. Transaction History

Fjarde Ap Fonden

$9.8 Billion
Q3 2024

A detailed history of Fjarde Ap Fonden transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Fjarde Ap Fonden holds 5,630 shares of CRL stock, worth $1.13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,630

Previous 6,530 13.78%

Holding current value

$1.13 Million

Previous $1.77 Million 37.31%

% of portfolio

0.01%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$187.96 - $245.29 $169,164 - $220,761	-900 Reduced 13.78%	5,630 $1.11 Million
Q1 2024 Apr 25, 2024	BUY	$203.52 - $273.43 $366,336 - $492,174	1,800 Added 38.05%	6,530 $1.77 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $575,820 - $835,940	3,500 Added 284.55%	4,730 $1.12 Million
Q3 2023 Oct 23, 2023	SELL	$194.44 - $217.61 $349,992 - $391,698	-1,800 Reduced 59.41%	1,230 $241,000
Q2 2023 Aug 02, 2023	SELL	$183.71 - $210.25 $183,710 - $210,250	-1,000 Reduced 24.81%	3,030 $637,000
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $498,913 - $675,792	-2,600 Reduced 39.22%	4,030 $813,000
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $1.32 Million - $1.68 Million	-6,700 Reduced 50.26%	6,630 $1.44 Million
Q2 2022 Aug 11, 2022	SELL	$204.13 - $302.4 $1.2 Million - $1.78 Million	-5,900 Reduced 30.68%	13,330 $2.85 Million
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $25,551 - $36,211	-100 Reduced 0.52%	19,230 $5.46 Million
Q4 2021 Feb 15, 2022	BUY	$351.38 - $448.68 $1.24 Million - $1.58 Million	3,530 Added 22.34%	19,330 $7.28 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $558,960 - $687,450	-1,500 Reduced 8.67%	15,800 $6.52 Million
Q2 2021 Aug 12, 2021	BUY	$294.17 - $371.65 $5.09 Million - $6.43 Million	17,300 New	17,300 $6.4 Million

Others Institutions Holding CRL

# of Institutions

698

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.2B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account